Journal of Immunology Research

Immunoregulation in Multiple Sclerosis: Pathogenesis and Therapeutic Implications

Publishing date
21 Mar 2014
Submission deadline
01 Nov 2013

1Department of Clinical Immunology, Hospital Clínico San Carlos, Madrid, Spain

2Inserm/Université U 1013, Hôpital Necker - Enfants Malades, Paris, France

3Department of Immunology, Germans Trias i Pujol University Hospital, Barcelona, Spain

This issue is now closed for submissions.

Immunoregulation in Multiple Sclerosis: Pathogenesis and Therapeutic Implications

This issue is now closed for submissions.


After trauma, multiple sclerosis (MS) represents the most common cause of neurological disability in young people, with a significant personal, social, and economic public health burden. MS is a chronic inflammatory demyelinating disease of the central nervous system, in which repeated episodes of autoimmune-mediated demyelination result in the formation of gliotic scar tissue plaques associated with varying degrees of axonal loss. Moreover, a defective immunoregulation has been demonstrated at different levels in MS, defect that can be partially restored by some therapies used for MS. A better knowledge of the interplaying factors that modulate the activation and/or function of immune cells will contribute to better understanding of the etiopathogenesis of MS and will enable the design of therapeutical strategies for individualized cell therapy. Potential topics include, but are not limited to:

  • Recent advances in immunopathogenesis of MS
  • Advances on immune targets for MS
  • Sex dimorphism and immunoregulation
  • Role of microbiota in MS
  • Vitamin D as an immunomodulator for MS
  • Immunoregulatory effects of MS therapies
  • Recent developments of therapies based on immunopathophysiology
  • Towards a personalized therapy for MS

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

Journal of Immunology Research
 Journal metrics
See full report
Acceptance rate17%
Submission to final decision83 days
Acceptance to publication26 days
Journal Citation Indicator0.560
Impact Factor4.1

Article of the Year Award: Impactful research contributions of 2022, as selected by our Chief Editors. Discover the winning articles.